Introduction and Objectives to Advances in Targeted Therapy for Small Cell Lung Cancer

Now Viewing

EP: 1.Introduction and Objectives to Advances in Targeted Therapy for Small Cell Lung Cancer

EP: 2.Goals of Therapy and Considerations for Treatment Sequencing in Extensive Stage Small Cell Lung Cancer

EP: 3.Exploring the Mechanisms of Action, Efficacy, Outcomes, and Future Potential of Bispecific T-Cell Engager Therapy in Advanced Small Cell Lung Cancer

EP: 4.The Emergence of B7-H3 Antibody-Drug Conjugates for the Treatment of Relapsed Small Cell Lung Cancer (SCLC) With a Review of the IDeate-Lung02 Clinical Trial

EP: 5.Evaluating the Anti-Tumor Activity of Lurbinectedin in the Treatment of Small Cell Lung Cancer, Which Has Progressed on or After Platinum-Based Chemotherapy

EP: 6.Final Remarks and Thank-You

Video content above is prompted by the following:

1. Describe the case and your initial impressions:.

2. What would be the predominant goals of therapy for a patient such as this?

3. In patients with extensive stage SCLC small cell lung cancer (ES-SCLC)that has developed progression, how do you balance the survival benefits afforded by subsequent lines of therapy with risks of treatment-related adverse events after progression of disease on platinum-based primary therapy?